YUNG Therapist Sidekick | $825,000 | (Oct 4, 2024)
Rezilient Health | $10,000,000 | (Oct 4, 2024)
kapa.ai | $3,200,000 | (Oct 4, 2024)
Promethean Particles
United Kingdom
- Nottingham, Nottinghamshire
- 15/08/2024
- Series A
- $10,277,840
Promethean Particles is a UK-based, global pioneer, leading the industrial-scale manufacture of metal-organic frameworks (MOFs). The Company is primarily focused on developing the use of MOFs in the fight against climate change, particularly for carbon capture, water harvesting, and gas storage applications. When compared to existing technologies, MOF-based carbon capture has the potential to deliver significant advantages; increased energy-efficiency, lower process complexity, smaller operating footprint, and an improved EHS profile.
Promethean has developed a range of patented continuous-flow reactors, which dramatically improve throughput and cost whilst increasing process reliability and consistency. The company operates a 1,000 tonnes per year reactor at its site in Nottingham, UK – the world’s largest continuous multi-nanomaterial manufacturing plant.
Promethean is collaborating with several different organisations to test MOFs in real-world environments and measure carbon capture effectiveness. Results from completed studies have been exciting, demonstrating that MOFs can significantly increase the efficiency and cost-effectiveness of CCS and leading to further projects. Larger-scale MOF-based CCS demonstration units are now planned on the path to full-scale implementation.
Contact us for more information and follow us on Twitter for our latest updates! @ProParticles
- Industry Chemical Manufacturing
- Website https://prometheanparticles.co.uk/
- LinkedIn https://www.linkedin.com/company/promethean-particles/
Related People
James StephensonFounder
United Kingdom -
Nottingham, England
Results-driven Executive P&L leader with extensive experience in large, global B2B multinationals now enjoying a new UK-based challenge as the leader of an early phase technology start-up. Skilled in leadership, general management, strategic business development, marketing, M&A, finance, and operations. Reputation for creating inventive strategies to drive profitable revenue growth and shareholder value across multiple industries. An inspirational leader and change agent, recognised for building high-performing teams, based on core values of integrity, initiative, & ownership.
KEY ACCOMPLISHMENTS
► PROFITABLE REVENUE GROWTH | P&L MANAGEMENT: Identified key strengths and weaknesses across the entire P&L to target commercial, product development and operational initiatives that drove 880bps improvement in operating income performance
► MERGERS & ACQUISITIONS STRATEGY, EXECUTION, AND INTEGRATION: Identified a portfolio of M&A targets to bolster existing business as well as a diversification strategy. Developed deal models for 4 targets, led due diligence and integration. All businesses performing ahead of deal model in 12 months
► STRATEGIC BUSINESS PLANNING: Proven track record for creating and delivering a variety of business strategies – organic, diversification and M&A - that link commercial activities, product development and operations directly to customer needs and corporate targets
► SALES STRATEGY AND PIPELINE DEVELOPMENT: Identified and prioritised target markets leading to 40% sales growth and increased key customer performance >10%. Increased the sales funnel by >$60M via focus on market driven business development. Reduced sales erosion from 15% to 7% by focusing on existing customers and aftermarket support
► PRODUCT DEVELOPMENT / INNOVATION PORTFOLIO TRANSFORMATION: Repeated experience in reinvigorating commercialisation processes to bring structure and speed to new market development. Deployed risk-based portfolio management to ensure expected rewards were commensurate with risk. Pioneer of “Agile” project management for marketing and new product development
► MULTI-FUNCTIONAL LEADERSHIP: Implemented standardised key performance indicators in combination with innovative approaches to directly align motivation and behaviour with critical strategic improvement goals
BROAD INDUSTRY & TECHNOLOGY EXPERIENCE including Transportation, Building & Construction, Electrical, Electronics, Medical Devices, Pharmaceuticals, Wind/Solar, Wire & Cable; Chemicals, Coatings/Paint, Composites, Oil and Gas, Plastics; Machinery & Engineered Equipment
Enara Bio | $32,500,000 | (Oct 4, 2024)
Paren | $3,000,000 | (Oct 4, 2024)
Avarra | $8,000,000 | (Oct 4, 2024)
Sober Sidekick by Empathy Health Tech | $2,800,000 | (Oct 4, 2024)
3Laws | $4,100,000 | (Oct 4, 2024)
Reducto | $8,400,000 | (Oct 4, 2024)
Integrated Biosciences, Inc. | $17,000,000 | (Oct 4, 2024)
Mstack Chemicals | $40,000,000 | (Oct 4, 2024)
FLORA (Flora Fertility) | $1,500,000 | (Oct 4, 2024)
AMAKA Studio | $2,000,000 | (Oct 4, 2024)